|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-17
|
|
pubmed:abstractText |
The aim of the present study was to evaluate the efficacy and safety of three doses of botulinum toxin type B (BoNT-B) in reducing persistent sialorrhoea in children with cerebral palsy (CP).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1469-8749
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© The Authors. Developmental Medicine & Child Neurology © 2011 Mac Keith Press.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
559-64
|
|
pubmed:meshHeading |
pubmed-meshheading:21413974-Adolescent,
pubmed-meshheading:21413974-Anti-Dyskinesia Agents,
pubmed-meshheading:21413974-Botulinum Toxins,
pubmed-meshheading:21413974-Cerebral Palsy,
pubmed-meshheading:21413974-Child,
pubmed-meshheading:21413974-Child, Preschool,
pubmed-meshheading:21413974-Dose-Response Relationship, Drug,
pubmed-meshheading:21413974-Female,
pubmed-meshheading:21413974-Follow-Up Studies,
pubmed-meshheading:21413974-Humans,
pubmed-meshheading:21413974-Male,
pubmed-meshheading:21413974-Salivary Glands,
pubmed-meshheading:21413974-Sialorrhea
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
|
|
pubmed:affiliation |
Unit of Neuro-Rehabilitation, Scientific Institute Hospital, IRCSS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
